Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
P&G: Dismal performance in FY01 - Views on News from Equitymaster
  • E-MAIL
  • A  A  A
  • Aug 28, 2001

    P&G: Dismal performance in FY01

    Procter & Gamble Hygiene and Healthcare Ltd. (PGHH) has reported a subdued performance for the year ended June 2001. While the company's revenues declined by 6%, profits were up by a marginal 10%.

    (Rs m) FY00 FY01 Change
    Sales 4,751 4,480 -5.7%
    Other Income 105 281 166.5%
    Expenditure 3,754 3,493 -7.0%
    Operating Profit (EBDIT) 997 988 -1.0%
    Operating Profit Margin (%) 21.0% 22.0%  
    Interest 41 3 -93.4%
    Depreciation 246 294 19.6%
    Profit before Tax 816 972 19.1%
    Extraordinary items 60 50 -16.2%
    Tax 126 196 55.5%
    Profit after Tax/(Loss) 750 827 10.2%
    Net profit margin (%) 15.8% 18.5%  
    No. of Shares (eoy) (m) 21.6 21.6  
    Diluted Earnings per share 34.7 38.2  
    P/E (at current price)   14  

    The sales figures in June '01 are however, not comparable as the previous year's figures included revenues from divested businesses such as manufacture of shampoos and Clearasil amounting to Rs 420 m. Excluding this, topline has actually grown by 3%. Strong competition from lower end brands has taken a toll on the company's volume growth.

    PGHH has successfully improved its operating margins (OPM) by 1% in FY01. The company's margins are the highest amongst its peers in the sector. Its focus on value growth has enabled it to maintain its OPM on the higher level. Also, removal of excise duty on feminine care products in the Union Budget 2000-01, has contributed in boosting the margins.

    Efficient working capital management has led to a decline in interest cost of the company by a significant 93% in FY01. PGHH's other income in FY01 grew by over 166%. The figure included proceeds from sale of some immovable properties at Mumbai. This company has repaid its debts with this additional inflow. Also, with no plans for further capacity addition, it has declared an extraordinary dividend of Rs 40 per share for the year. This would enhance its returns on capital employed from 39% in FY00 to about 48% in FY01.

    At the current market price of Rs 530 PGHH is trading at a P/E of 14x and market cap to sales ratio of 2.6x on FY01 earnings. The stock is accorded lower valuations by the markets because of the company's dependence on two brands. P&G's (parent company) wholly owned subsidiary, P&G Home Products Ltd. has also raised concerns among the investors.



    Equitymaster requests your view! Post a comment on "P&G: Dismal performance in FY01". Click here!


    More Views on News

    P&G: Strong Core Growth (Quarterly Results Update - Detailed)

    Dec 9, 2016

    Procter & Gamble Hygiene and Health Care has announced the first quarter results of the financial year ended June 2017 (1QFY17). The company's sales rose by 12.5%YoY while net profit rose by 50.1% YoY during the quarter.

    P&G: Strong Core Performance (Quarterly Results Update - Detailed)

    Oct 5, 2016

    Procter & Gamble Hygiene and Health Care reported a 0.1% YoY growth in sales and a 2.2% YoY increase in net profits during the quarter ended June 2016.

    Marico: Earnings Hit by Lower Volumes and Firming Input Prices (Quarterly Results Update - Detailed)

    Aug 9, 2017

    While GST implementation brought down volumes and profitability in the short run, Marico remains optimistic in the long run.

    P&G: A Stable Quarter (Quarterly Results Update - Detailed)

    May 6, 2016

    Procter & Gamble Hygiene and Health Care reported an 11% YoY increase in revenues, while profits rose by 12% YoY during the quarter.

    P&G: Margins Go Through the Roof (Quarterly Results Update - Detailed)

    Feb 9, 2016

    Procter & Gamble Hygiene and Health Care reported an 11% YoY increase in revenues, while profits rose by 62% YoY during the quarter.

    More Views on News

    Most Popular

    Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

    Aug 7, 2017

    The data tells us quite a different story from the one the government is trying to project.

    Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

    Aug 4, 2017

    The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

    Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

    Aug 8, 2017

    Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

    Signs of Life in the India VIX(Daily Profit Hunter)

    Aug 12, 2017

    The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

    7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

    Aug 7, 2017

    Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

    Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
    Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

    LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

    SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

    Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
    Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

    Become A Smarter Investor In
    Just 5 Minutes

    Multibagger Stocks Guide 2017
    Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
    We will never sell or rent your email id.
    Please read our Terms


    Aug 16, 2017 (Close)


    • Track your investment in P&G HYGIENE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
    • Add To MyStocks


    Detailed Financial Information With Charts